Cytopoint Logo

CYTOPOINT Resources and Graphics

Presented by Zoetis

These resources are available to journalists interested in CYTOPOINT, canine atopic dermatitis and how monoclonal antibodies (mAbs) are used in veterinary medicine.

Monoclonal antibody (mAb) therapy is the fastest growing class of therapeutics in human medicine. Zoetis researchers have now introduced this therapy into veterinary medicine with CYTOPOINT, the first mAb licensed for the treatment of canine atopic dermatitis. CYTOPOINT is a veterinarian-administered injectable that helps provide fast, effective and long-lasting relief of clinical signs in dogs with atopic dermatitis.